Key result
Vascular Health Profile predicts incident CV events over three years exclusively among diabetic patients.
Why the study?
The Vascular Health Profile (VHP) was developed to differentiate vascular status in diabetics versus healthy controls and to evaluate its ability to predict cardiovascular events over 3 years.
Does the Vascular Health Profile predict cardiovascular outcomes in patients with diabetes?
Cohort (n=87)
Does the Vascular Health Profile predict cardiovascular outcomes in patients with diabetes?
The Vascular Health Profile, a blood test measuring progenitor cells and extracellular vesicles, significantly predicts cardiovascular events in patients with diabetes.
Answers are grounded in this paper and cite their sources.
VHP may stratify CV event risk in diabetes; hypothesis-generating and requires prospective validation before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rogers et al. (2015) conducted a cohort in Diabetes (n=87). Vascular Health Profile (VHP) was evaluated on Cardiovascular events (myocardial infarction, stroke, major adverse cardiovascular events, revascularization, and irregular rhythm).
Synapse has enriched 10 related papers. Consider them for comparative context: